{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04119037",
            "orgStudyIdInfo": {
                "id": "2019-0264"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2019-03708",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "2019-0264",
                    "type": "OTHER",
                    "domain": "M D Anderson Cancer Center"
                },
                {
                    "id": "R01NR018481",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01NR018481"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Cordotomy in Reducing Pain in Patients With Advanced Cancer",
            "officialTitle": "Percutaneous Cordotomy for Pain Palliation in Advanced Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "cordotomy-in-reducing-pain-in-patients-with-advanced-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-09-16",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-09-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-09-11",
            "studyFirstSubmitQcDate": "2019-10-04",
            "studyFirstPostDateStruct": {
                "date": "2019-10-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-11",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Cancer Institute (NCI)",
                    "class": "NIH"
                },
                {
                    "name": "National Institute of Nursing Research (NINR)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This trial studies how well cordotomy works in reducing pain in patients with cancer that has spread to other places in the body (advanced). Cordotomy is performed on the spinal cord with a needle and guided by computed tomography scans and is designed to help reduce pain. This study is being done to learn if a cordotomy reduces pain in patients with unmanageable cancer pain.",
            "detailedDescription": "PRIMARY OBJECTIVES:\n\nI. Assess the efficacy of cordotomy for patients with unilateral advanced cancer pain.\n\nSECONDARY OBJECTIVES:\n\nI. Define the patient experience of cordotomy for cancer pain refractory to palliative care.\n\nII. Determine whether magnetic resonance imaging (MRI) can be used as a noninvasive biomarker for a successful cordotomy.\n\nOUTLINE: Patients are randomized to 1 of 2 groups.\n\nGROUP I: Patients undergo a cordotomy over 1-2 hours.\n\nGROUP II: Patients receive morphine via injection into the spine and undergo a fake cordotomy over 1-2 hours.\n\nAfter completion of study, patients are followed up at 2 weeks and once every month for up to 6 months."
        },
        "conditionsModule": {
            "conditions": [
                "Advanced Malignant Neoplasm"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 42,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Group I (cordotomy)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients undergo a cordotomy over 1-2 hours.",
                    "interventionNames": [
                        "Procedure: Cordotomy",
                        "Other: Questionnaire Administration"
                    ]
                },
                {
                    "label": "Group II (morphine, fake cordotomy)",
                    "type": "SHAM_COMPARATOR",
                    "description": "Patients receive morphine via injection into the spine and undergo a fake cordotomy over 1-2 hours.",
                    "interventionNames": [
                        "Drug: Morphine",
                        "Other: Questionnaire Administration",
                        "Procedure: Sham Intervention"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Cordotomy",
                    "description": "Undergo cordotomy",
                    "armGroupLabels": [
                        "Group I (cordotomy)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Morphine",
                    "description": "Given via injection",
                    "armGroupLabels": [
                        "Group II (morphine, fake cordotomy)"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Questionnaire Administration",
                    "description": "Ancillary studies",
                    "armGroupLabels": [
                        "Group I (cordotomy)",
                        "Group II (morphine, fake cordotomy)"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Sham Intervention",
                    "description": "Undergo fake cordotomy",
                    "armGroupLabels": [
                        "Group II (morphine, fake cordotomy)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Reduction in pain intensity",
                    "description": "Will be measured by the Edmonton Symptom Assessment Scale (ESAS).",
                    "timeFrame": "Up to 6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Brief Pain Inventory pain interference items",
                    "description": "Will provide initial estimates of the magnitude of the effect of cordotomy.",
                    "timeFrame": "Up to 6 months"
                },
                {
                    "measure": "Other ESAS symptoms",
                    "description": "Will provide initial estimates of the magnitude of the effect of cordotomy.",
                    "timeFrame": "Up to 6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Ability to provide informed consent\n* Has undergone 3 palliative care evaluations\n* Pain intensity \\>= 4 on a 0-10 numerical scale\n* Unilateral pain due to cancer below the shoulder level (arm, trunk, hip, leg)\n\nExclusion Criteria:\n\n* Uncorrectable coagulopathy\n* Large intracranial mass\n* Inability to complete assessment forms\n* Life expectancy \\< 1 month\n* Contraindication to intravenous sedation\n* Morphine allergy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Eduardo Bruera",
                    "role": "CONTACT",
                    "phone": "713-792-6084",
                    "email": "ebruera@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Eduardo Bruera",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "M D Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Eduardo Bruera",
                            "role": "CONTACT",
                            "phone": "713-792-6084"
                        },
                        {
                            "name": "Eduardo Bruera",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "MD Anderson Cancer Center Website",
                    "url": "http://www.mdanderson.org"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009020",
                    "term": "Morphine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000701",
                    "term": "Analgesics, Opioid"
                },
                {
                    "id": "D000009294",
                    "term": "Narcotics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11982",
                    "name": "Morphine",
                    "asFound": "400",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M12245",
                    "name": "Narcotics",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}